IIM
LUCD icon

INTECH Investment Management’s Lucid Diagnostics LUCD Stock Holding History

INTECH Investment Management’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.1K Buy
36,526
+13,245
+57% +$14.3K ﹤0.01% 2078
2026
Q1 		$26.8K Sell
23,281
-10,697
-31% -$13.6K ﹤0.01% 2056
2025
Q4 		$37K Buy
33,978
+3,889
+13% +$4.35K ﹤0.01% 2282
2025
Q3 		$30.4K Sell
30,089
-6,265
-17% -$6.84K ﹤0.01% 2390
2025
Q2 		$41.8K Buy
+36,354
New +$47K ﹤0.01% 2431

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

INTECH Investment Management's LUCD Position: Q2 2026 in Review

INTECH Investment Management increased its Lucid Diagnostics (LUCD) stake by 57% in Q2 2026, buying an estimated $14.3K and bringing the position to 36,526 shares worth $39.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2078.

INTECH Investment Management first reported a position in LUCD in Q2 2025 and has held it in 5 quarters since. The position peaked at $41.8K in Q2 2025. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • INTECH Investment Management held 36,526 shares of Lucid Diagnostics worth $39.1K as of Q2 2026.
  • INTECH Investment Management bought 13,245 Lucid Diagnostics shares in Q2 2026, an estimated $14.3K.
  • Lucid Diagnostics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #2078 holding.
  • INTECH Investment Management first reported a position in Lucid Diagnostics in Q2 2025 and has held it in 5 quarters since.
  • INTECH Investment Management's Lucid Diagnostics position peaked at $41.8K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.